Skip to content

Journal of Psychoactive Drugs

ISSN 0279-1072, 2159-9777

419 papers in the library · 13,118 citations · publishing 1976-2026

Papers

Sort Most recent Most cited

Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay.

Journal of Psychoactive Drugs 2023 Ismael Apud, Juan Scuro, Luisina Rodríguez et al. 4 citations

This study is an interdisciplinary research into Uruguayan ayahuasca users belonging to one neo-shamanic and one Santo Daime group. The study involved the chemical analysis of ayahuasca samples, an ethnographic description of the two traditions and rituals, and the application of psychometric scales to measure personality differences, and the acute psychological effects during an ayahuasca...

DOI: 10.1080/02791072.2023.2261017 (opens in new tab) Full text (opens in new tab) Santo daime Acute psychological effects Neo-shamanism Personality +6

Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.

Journal of Psychoactive Drugs 2023 Daniel J. Kruger, Julie Barron, Moss Herberholz et al. 4 citations

Legal, scientific, and social landscapes for psychedelics are changing rapidly. Differences of opinion exist among key stakeholders regarding regulatory control, models of provisioning psychedelic therapy, and medicalization, decriminalization, and/or legalization policies. We assessed the policy preferences of people using psychedelics naturalistically (N = 1221) to understand how they aligned...

DOI: 10.1080/02791072.2023.2228784 (opens in new tab) Full text (opens in new tab) Psychedelics Community-based research Policy Preferences

Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing.

Journal of Psychoactive Drugs 2023 Tianhong Tim Qiu, John Paul Minda 3 citations

Both psychedelics and mindfulness are recently emerging topics of interest in academia and popular culture. The Prevalence of personal meditation practices and recreational psychedelic use has consistently increased in the past decade. While clinical work has shown both to improve long-term wellbeing, data on naturalistic applications of psychedelics and mindfulness are lacking. The current...

Neural Plasticity in the Ventral Tegmental Area, Aversive Motivation during Drug Withdrawal and Hallucinogenic Therapy.

Journal of Psychoactive Drugs 2023 Hector Vargas-Perez, Taryn Elizabeth Grieder, Derek van der Kooy

Aberrant glutamatergic signaling has been closely related to several pathologies of the central nervous system. Glutamatergic activity can induce an increase in neural plasticity mediated by brain-derived neurotrophic factor (BDNF) in the ventral tegmental area (VTA), a nodal point in the mesolimbic dopamine system. Recent studies have related BDNF dependent plasticity in the VTA with the...

The Naturalistic Cannabis Administration Protocol (NCAP): A Proof-of-Concept Study.

Journal of Psychoactive Drugs 2023 Michelle St Pierre, Sarah Daniels, Tatiana A Sanchez et al.

Lab-based studies examining the effects of cannabis administration on human behavior compromise ecological validity due to the influence of set and setting. Contextual factors of clinical settings have long been recognized as producing measurable changes in physiology, emotionality, and cognition. Among people who use drugs, these settings may be associated with higher levels of perceived...

DOI: 10.1080/02791072.2022.2125466 (opens in new tab) Full text (opens in new tab) Methodology Acute cannabis intoxication Cannabis research Experimental design

Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge

Journal of Psychoactive Drugs 2023

The global prevalence of substance abuse and mental disorders continues to challenge healthcare systems, with one in eight individuals affected. The therapeutic potential of psychedelics is recognized not only for treating mental disorders but also for enhancing well-being and promoting pro-social behaviors. Conventional biomedical research models fall short in addressing the broader health...

Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies

Journal of Psychoactive Drugs October 11, 2022 Jeremy Weleff, Teddy J. Akiki, Brian S. Barnett 11 citations

Following a decades long period of investigational dormancy, there is renewed interest in employing psychedelics as psychiatric treatments. The academic journals, institutions, and countries that have helped sustain clinical psychedelic research and the evolution of the literature on clinical studies of psychedelics have only recently begun to be investigated. To expand upon this work, we...

Predictors of Psychedelic Experience: A Thematic Analysis

Journal of Psychoactive Drugs October 5, 2022 Annie M. Mccartney, Hugh McGovern, Alexander de Foe 33 citations

Research on the therapeutic potential of psychedelic substances is expanding. A limitation within this field is the unpredictability of individual responses to psychedelics. Better understanding of factors predicting psychedelic experience is essential to clinical progress and wider harm reduction frameworks. Ketamine, MDMA, LSD and psilocybin were selected for comparison due to their promising...

The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness

Journal of Psychoactive Drugs August 19, 2022 Marcio S. C. Longo, Bheatrix Bienemann, Marco Multedo et al. 10 citations

This study sought to investigate the effects of different substances on nature relatedness (NR) in the general population. An online cross-sectional survey done in Brazil investigated use of ayahuasca/DMT, psilocybe mushrooms, LSD, MDMA/ecstasy, cocaine, cannabis, and alcohol. NR was assessed using the short-form version of the nature related scale (NR-6). One-way analysis of variance (ANOVA)...

Naturalistic Psychedelic Use: A World Apart from Clinical Care

Journal of Psychoactive Drugs August 11, 2022 Nicolas G. Glynos, Christopher W Fields, Julie Barron et al.

ABSTRACT Interest in and availability of psychedelics for therapeutic purposes has increased in recent decades. In a large, anonymous, online survey, we investigated patterns of communication with healthcare providers and awareness and utilization of substance testing kits or services among people using psychedelics naturalistically. The sample population included attendees of a psychedelic...

A Dose of Creativity: An Integrative Review of the Effects of Serotonergic Psychedelics on Creativity

Journal of Psychoactive Drugs July 27, 2022 M. Costa

ABSTRACT This integrative review was conducted to summarize the knowledge pertaining to the effects that serotonergic psychedelics can have on creativity, a multi-dimensional construct referring to the ability to produce original and valuable artifacts. Psychedelics, which have long been hailed as substances that can enhance the creative process in their users, have experienced a recent...

Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study

Journal of Psychoactive Drugs June 12, 2022 Vincent Hartong, Arnold A P Van Emmerik 11 citations

While anecdotal reports claim that psychedelic microdosing reduces anxiety and mood symptoms, evidence supporting these claims is scarce. This cross-sectional study investigated the association between microdosing and trait anxiety. Furthermore, it was investigated if trait mindfulness mediated this association. Participants completed anonymous online questionnaires and were divided into three...

DOI: 10.1080/02791072.2022.2080616 (opens in new tab) Mindfulness Clinical psychology Mediation Association psychology +3

Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands

Journal of Psychoactive Drugs May 28, 2022 Maja Kohek, Genís Ona, Michiel van Elk et al. 25 citations

Ayahuasca is a plant decoction in traditional Amazonian medicine. Its ritual use has been internationalized, leading to policy challenges that countries should address. This study evaluates the impact of regular ayahuasca ceremony participation on health by assessing the health status of 377 participants in ayahuasca ceremonies in the Netherlands using validated health indicators. A...

Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay

Journal of Psychoactive Drugs May 4, 2022 Ismael Apud, Juan Scuro, Ignacio Carrera et al. 14 citations

The current article presents a mixed qualitative-quantitative observational study of the effect of ayahuasca ritual on subjective experiences and personality traits on participants of a center specialized in the treatment of substance use disorder in Uruguay. When comparing the psychological traits of ayahuasca participants to a control group, quantitative results using the...

Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users

Journal of Psychoactive Drugs April 6, 2022 Baptiste Fauvel, Kangaslampi Samuli, Strika-Bruneau Lana et al.

ABSTRACT Mystical experiences triggered by psychedelic drugs predict symptom reduction in various psychiatric disorders, and increased well-being in healthy individuals. This work aimed at validating a French version of a tool used to measure mystical experiences: the Revised Mystical Experience Questionnaire-30 items (MEQ30). Construct validity, internal consistencies, concurrent,...

How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?

Journal of Psychoactive Drugs March 23, 2022 Mitch Earleywine, Fiona Low, Brianna R. Altman et al. 31 citations

Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the...

DOI: 10.1080/02791072.2022.2047842 (opens in new tab) Psilocybin Cognition Clinical psychology Psychotherapist +3

Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences

Journal of Psychoactive Drugs March 22, 2022 Lindsay Shaw, Kerri Rea, Nathan J. Lachowsky et al. 11 citations

The field of psychedelic research is undergoing a revival, yet research focused on non-clinical psychedelic use remains relatively limited. The current qualitative study sheds light on how people use magic mushrooms, what they perceive the effects of such use to be, and the meanings that users attach to their magic mushroom experiences. To be eligible to participate in the study, participants...

DOI: 10.1080/02791072.2022.2054746 (opens in new tab) Magic telescope Mushroom Qualitative research Magic bullet +2

The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review

Journal of Psychoactive Drugs February 28, 2022 Andrew Hodge, Suporn Sukpraprut‐braaten, Matthew R Narlesky et al. 47 citations

There has been a reemergence of research into the use of substances such as LSD, MDMA, and psilocybin for the treatment of psychiatric disorders. This increase in consideration toward the medicinal use of these compounds has been termed the "Psychedelic Renaissance." This article specifically explores the background of psilocybin, a psychoactive compound that is naturally derived from certain...

Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms

Journal of Psychoactive Drugs January 27, 2022 Ciarán Martin Fitzpatrick, B. Anderson, Gabrielle Agin-Liebes et al. 1 citation

The Journal of Psychoactive Drugs published a case study reporting reduction of obsessive-compulsive disorder (OCD) symptoms after consumption of psilocybincontaining mushrooms (Lugo-Radillo & Cortes-Lopez, 2021).We subsequently received a letter suggesting that psychedelic research has progressed beyond case studies, and recommending that journals focus on publication of clinical trials rather...

Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America

Journal of Psychoactive Drugs January 11, 2022 Terence H. W. Ching, Alan K. Davis, Yitong Xin et al. 34 citations

There is a need to understand ways in which Asians in North America attempt to heal from racial trauma, given their well-documented high risk of exposure and associated adverse mental health outcomes. We conducted a secondary analysis of Asians from a survey of people of color in North America who have consumed psychedelics in response to racial discrimination. Ninety-two Asian participants...

DOI: 10.1080/02791072.2022.2025960 (opens in new tab) Ethnic group Mediation Demographics Clinical psychology +2

Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia

Journal of Psychoactive Drugs January 10, 2022 Nicolas G. Glynos, Jennifer Pierce, Alan K. Davis et al. 39 citations

Fibromyalgia (FM) is a difficult to treat chronic pain condition for which there is strong interest in alternative treatments. There is growing interest in the potential of psychedelic substances (e.g., psilocybin) in conjunction with psychotherapy to treat chronic pain. Via a cross-sectional, anonymous, online survey, we aimed to characterize knowledge, perceptions, and past use of...

Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression

Journal of Psychoactive Drugs January 3, 2022 Brianna R. Altman, Mitch Earleywine, Joseph A. de Leo 4 citations

Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of...

DOI: 10.1080/02791072.2021.2020382 (opens in new tab) Psilocybin Credibility Psychological intervention Clinical psychology +6

Spiritual Benefit from Cannabis.

Journal of Psychoactive Drugs 2022 Frederick J. Heide, Tai Chang, Natalie Porter et al.

Like many mind-altering plants, cannabis has been part of spiritual practices for thousands of years. It has deep roots in Hinduism, Islam, Rastafarianism, and indigenous traditions in Asia, Africa, and elsewhere. Yet almost no attention has been given to how contemporary adults employ it spiritually. A sample of 1087 participants (mean age = 38.9) completed an online survey assessing their use...

Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study

Journal of Psychoactive Drugs November 25, 2021 Tomislav Majić, Lasse Brandt, Christiane Montag 3 citations

3,4-methylenedioxymethamphetamine (MDMA/"ecstasy") is widespread in the electronic club scene, but MDMA has also been suggested for the treatment of anxiety spectrum disorders like posttraumatic stress disorder (PTSD) and social anxiety in autistic adults. Here, we report a case of a high functioning 24-old student with a sporadic recreational use of ecstasy, and a history of a single episode...

Ayahuasca Lyophilization (Freeze-drying) Protocol with Pre- and Post-procedure Alkaloids Quantification

Journal of Psychoactive Drugs September 17, 2021 Dimitri Daldegan-Bueno, Vanessa Manchim Favaro, Luís Fernando Tófoli et al. 6 citations

Ayahuasca is a psychoactive brew from the decoction of different Amazonian plants, traditionally used in several cultures, religions, and rituals. Scientific studies with ayahuasca are rapidly increasing due to its subjective effects and therapeutic potential. Although ayahuasca is traditionally used in its liquid presentation, lyophilized (freeze-dried) ayahuasca is often used in scientific...

DOI: 10.1080/02791072.2021.1971342 (opens in new tab) Ayahuasca Freeze-drying Decoction Chromatography +1